MET and neoplasm: Assuming that the driver mutations in genes such as EGFR, ALK, ROS1, HER2, and MET (among others) had demonstrated advantages favoring cell transformation, leading to the expansion of the altered clone, which could be followed by tumor formation and its evolution.